Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients

British Journal of Cancer

Volumn 107, Issue 2, 2012, Pages 266-274

  Tarantino, I ^a   Warschkow, R ^a,b   Worni, M ^c   Merati Kashani, K ^a   Koberle D ^a   Schmied, B M ^a   Muller S A ^a   Steffen, T ^a   Cerny, T ^a   Guller U ^a,c  

^a Kantonsspital St Gallen ^*  (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

CEA; overall survival; rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECTUM CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOEMBRYONIC ANTIGEN; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL RATE; SWITZERLAND;

EID: 84863722095     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.267     Document Type: Article

References (30)

1. AJCC (2010) In AJCC Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds). 7th edn, Vol X, 646pp, 130 illus. with CD-ROM. ISBN 978-0-387-88440-0. Springer: New York
2. Boonpipattanapong T, Chewatanakornkul S (2006) Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol 40(7): 592-595
3. Cancer-Statistics US (2010) US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007
4. Chapman MA, Buckley D, Henson DB, Armitage NC (1998) Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer 78(10): 1346-1349
5. Diez M, Pollan M, Muguerza JM, Gaspar MJ, Duce AM, Alvarez MJ, Ratia T, Hernandez P, Ruiz A, Granell J (2000) Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer 88(1): 35-41
6. Fueglistaler P, Adamina M, Guller U (2007) Non-inferiority trials in surgical oncology. Ann Surg Oncol 14(5): 1532-1539
7. Govindarajulu US, Lin H, Lunetta KL, D'Agostino Sr RB (2011) Frailty models: applications to biomedical and genetic studies. Stat Med 30(22): 2754-2764
8. Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T (2007) Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol 33(2): 183-187
9. Hansen BB, Klopfer Olsen S (2006) Optimal full matching and related designs via network flows. J Computat Graphical Statistics 15(3): 609-627
10. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron WAltekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (2011) (eds). SEER Cancer Statistics Review, 1975-2008. National Cancer Institute: Bethesda, MD. http://seer.cancer. gov/csr/1975-2008/, based on November 2010 SEER data submission, posted to the SEER web site
11. Kim JY, Kim NK, Sohn SK, Kim YW, Kim KJ, Hur H, Min BS, Cho CH (2009) Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol 16(10): 2771-2778
12. Knight CD, Griffen FD (1980) An improved technique for low anterior resection of the rectum using the EEA stapler. Surgery 88(5): 710-714
13. Li M, Li JY, Zhao AL, He JS, Zhou LX, Li YA, Gu J (2009) Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer. Colorectal Dis 11(3): 276-281
14. Lin JK, Lin CC, Yang SH, Wang HS, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC (2011) Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis 26(9): 1135-1141
15. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast Jr RC (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24(33): 5313-5327
16. NCCN (2012) National Comprehensive Cancer Network (NCCN) guidelines. http://www.nccn.org/index.asp (last accessed 12 March 2012)
17. Park IJ, Choi GS, Lim KH, Kang BM, Jun SH (2009) Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol 16(11): 3087-3093
18. Park YA, Lee KY, Kim NK, Baik SH, Sohn SK, Cho CW (2006) Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 13(5): 645-650
19. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108
20. Perez RO, Sao Juliao GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I (2009) The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum 52(6): 1137-1143
21. Rosenbaum PRaDBR (1985) Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. American Statistician 39(1): 33-38
22. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127(8 Part 2): 757-763
23. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17): 1731-1740
24. SGGSSG (2007) Konsensus-Empfehlungen zur Nachsorge nach kurativ operiertem kolorektalem Karzinom. Schweizerische Gesellschaft für Gastroenterologie. http://www.sggssg.ch/Dokumente/Merkblaetter/NaSo-CRC-d.pdf, last accessed 7 May 2012
25. Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY (2009) Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer 9: 288
26. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H (2008) Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 15(12): 3433-3439
27. Thirunavukarasu P, Sukumar S, Sathaiah M, Mahan M, Pragatheeshwar KD, Pingpank JF, Zeh 3rd H, Bartels CJ, Lee KK, Bartlett DL (2011) C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. J Natl Cancer Inst 103(8): 689-697
28. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299(9): 448-451
29. Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S, Noshiro H, Miyazaki K (2010) Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol 17(9): 2349-2356
30. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D (1998) Surgical treatment of adenocarcinoma of the rectum. Ann Surg 227(6): 800-811